Literature DB >> 25561366

Paediatric rheumatology in 2014: Digging deeper for greater precision and more impact in JIA.

Berent Prakken1, Alberto Martini2.   

Abstract

Optimizing the management of childhood arthritis requires detailed knowledge of the disease in an individual patient. Advances in 2014 show how in-depth genetic studies and insights into immunopathogenesis could translate into clinical biomarkers and, eventually, individualized therapy.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25561366     DOI： 10.1038/nrrheum.2014.224

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


  10 in total

1.  Quantification of the familial contribution to juvenile idiopathic arthritis.

Authors:  Sampath Prahalad; Andrew S Zeft; Richard Pimentel; Bronte Clifford; Bernadette McNally; Geraldine P Mineau; Lynn B Jorde; John F Bohnsack
Journal:  Arthritis Rheum       Date:  2010-08

2.  Self-reported pain and disease symptoms persist in juvenile idiopathic arthritis despite treatment advances: an electronic diary study.

Authors:  Maggie H Bromberg; Mark Connelly; Kelly K Anthony; Karen M Gil; Laura E Schanberg
Journal:  Arthritis Rheumatol       Date:  2014-02       Impact factor: 10.995

3.  Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis.

Authors:  Salma M Wakil; Dorota M Monies; Mohamed Abouelhoda; Nada Al-Tassan; Haya Al-Dusery; Ewa A Naim; Banan Al-Younes; Jameela Shinwari; Futwan A Al-Mohanna; Brian F Meyer; Sulaiman Al-Mayouf
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

Review 4.  Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Authors:  Elizabeth D Mellins; Claudia Macaubas; Alexei A Grom
Journal:  Nat Rev Rheumatol       Date:  2011-06-07       Impact factor: 20.543

Review 5.  Juvenile idiopathic arthritis.

Authors:  Berent Prakken; Salvatore Albani; Alberto Martini
Journal:  Lancet       Date:  2011-06-18       Impact factor: 79.321

6.  Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.

Authors:  Dirk Foell; Nico Wulffraat; Lucy R Wedderburn; Helmut Wittkowski; Michael Frosch; Joachim Gerss; Valda Stanevicha; Dimitrina Mihaylova; Virginia Ferriani; Florence Kanakoudi Tsakalidou; Ivan Foeldvari; Ruben Cuttica; Benito Gonzalez; Angelo Ravelli; Raju Khubchandani; Sheila Oliveira; Wineke Armbrust; Stella Garay; Jelena Vojinovic; Ximena Norambuena; María Luz Gamir; Julia García-Consuegra; Loredana Lepore; Gordana Susic; Fabrizia Corona; Pavla Dolezalova; Angela Pistorio; Alberto Martini; Nicolino Ruperto; Johannes Roth
Journal:  JAMA       Date:  2010-04-07       Impact factor: 56.272

Review 7.  Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis.

Authors:  Sebastiaan Vastert; Berent Prakken
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-04       Impact factor: 4.098

8.  Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial.

Authors:  Hermine I Brunner; Nicolino Ruperto; Zbigniew Zuber; Caroline Keane; Olivier Harari; Andrew Kenwright; Peng Lu; Ruben Cuttica; Vladimir Keltsev; Ricardo M Xavier; Inmaculada Calvo; Irina Nikishina; Nadina Rubio-Pérez; Ekaterina Alexeeva; Vyacheslav Chasnyk; Gerd Horneff; Violetta Opoka-Winiarska; Pierre Quartier; Clovis A Silva; Earl Silverman; Alberto Spindler; Eileen Baildam; M Luz Gámir; Alan Martin; Christoph Rietschel; Daniel Siri; Elzbieta Smolewska; Daniel Lovell; Alberto Martini; Fabrizio De Benedetti
Journal:  Ann Rheum Dis       Date:  2014-05-16       Impact factor: 19.103

9.  Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis.

Authors:  David Bending; Anne M Pesenacker; Simona Ursu; Qiong Wu; Hannah Lom; Balathas Thirugnanabalan; Lucy R Wedderburn
Journal:  J Immunol       Date:  2014-08-04       Impact factor: 5.422

10.  Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity.

Authors:  Thomas Vogl; Michel Eisenblätter; Tom Völler; Stefanie Zenker; Sven Hermann; Peter van Lent; Andreas Faust; Christiane Geyer; Beatrix Petersen; Kirsten Roebrock; Michael Schäfers; Christoph Bremer; Johannes Roth
Journal:  Nat Commun       Date:  2014-08-06       Impact factor: 14.919
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.